The Korean Journal of Clinical Laboratory Science : eISSN 2288-1662 / pISSN 1738-3544

Fig. 1.

Download original image
Fig. 1. Effect of MC38/CEA2 tumors for treatment with various doses of cyclophosphamide. (A) Schematic representation of the experimental groups and schedule. Mice were subcutaneously given 1×106 MC38/CEA2 cells on day 0 in the right flank. On days 2 (B) or days 10 (C), the mice received 100 mg/kg (○), 50 mg/kg (◇), 25 mg/kg (●), 12.5 mg/kg (■) of cyclophosphamide intraperitoneal, respectively. The results represent the average values±SD of ten mice per group in a representative experiment of three separate experiments. ***P<0.001 compared with the CYP 50 mg/kg group.
Korean J Clin Lab Sci 2022;54:38-48 https://doi.org/10.15324/kjcls.2022.54.1.38
© 2022 Korean J Clin Lab Sci